Published in J Toxicol on April 29, 2009
Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry (2012) 0.86
Drugs of Abuse in Human Milk Purchased via the Internet. Breastfeed Med (2015) 0.75
Transfer of drugs and other chemicals into human milk. Pediatrics (2001) 4.17
Relationship of sudden infant death syndrome to maternal smoking during and after pregnancy. Pediatrics (1992) 3.86
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet (1987) 3.61
Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry (2001) 3.36
Cannabis use and mental health in young people: cohort study. BMJ (2002) 3.26
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74
Drug use among adolescent mothers: prepregnancy to 18 months postpartum. J Adolesc Health (1996) 1.56
Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol (1999) 1.50
Cigarette smoke exposure and development of infants throughout the first year of life: influence of passive smoking and nursing on cotinine levels in breast milk and infant's urine. Acta Paediatr (1992) 1.41
High prevalence rates of tobacco, alcohol and drug use in adolescents and young adults in France: results from the GAZEL Youth study. Addict Behav (2007) 1.28
Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med (1982) 1.26
Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol (1990) 1.22
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Eur J Pharmacol (2003) 1.11
Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp Biol Med (Maywood) (2005) 1.07
Marijuana: prenatal and postnatal exposure in the human. NIDA Res Monogr (1985) 0.99
Maternal and paternal recreational drug use and sudden infant death syndrome. Arch Pediatr Adolesc Med (2001) 0.95
Cannabinoids and gene expression during brain development. Neurotox Res (2004) 0.93
Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development. J Neuroendocrinol (2008) 0.90
Breast-feeding and drug exposure. Obstet Gynecol Clin North Am (1998) 0.83
Prenatal exposure to cannabis: a preliminary report of postnatal consequences in school-age children. Neurotoxicol Teratol (1992) 0.81
Breastfeeding and the use of recreational drugs--alcohol, caffeine, nicotine and marijuana. Breastfeed Rev (1998) 0.80
Passive consumption of marijuana through milk: a low level chronic exposure to delta-9-tetrahydrocannabinol(THC). J Toxicol Clin Toxicol (1990) 0.79
Mother's milk and the muffin man: grassroots innovations in medical marijuana delivery systems. J Ethn Subst Abuse (2005) 0.78
Behavioral effects of hashish in mice. II. Nursing behavior and development of the sucklings. Psychopharmacology (Berl) (1980) 0.78
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet (2011) 1.12
Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension (2006) 1.02
Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension (2013) 0.98
Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation. BMC Genomics (2005) 0.97
Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J Cyst Fibros (2013) 0.94
Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1. J Immunol (2005) 0.89
Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas. Epigenetics (2011) 0.86
Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics (2010) 0.86
Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One (2012) 0.85
Ibuprofen concentrations in human mature milk--first data about pharmacokinetics study in breast milk with AOR-10127 "Antalait" study. Ther Drug Monit (2014) 0.85
Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: study protocol for a randomized controlled trial. Trials (2011) 0.81
Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology (2007) 0.80
Disseminated congenital toxoplasma infection with a type II strain. Pediatr Infect Dis J (2011) 0.76
Using anti-cancer agents during the post-partum period: not that simple. Onkologie (2010) 0.75
[Preeclampsia]. Med Sci (Paris) (2008) 0.75